GALWAY, IRELAND--February 9, 2021--Written by Martin Lynch, European News Editor for Industrial Info (Galway, Ireland)--The Pfizer/BioNTech duo has completed the manufacturing upgrades needed to overcome recent European delays in the production of its COVID-19 vaccine and has promised an extra 75 million doses by Spring.

Within this article: Details production upgrades for extra vaccine rollout, plants, deals with rivals to boost production